Ticker LaunchFiled, not priced · EMI
Encore Medical, Inc.
Encore Medical, Inc. publicly filed a registration statement on Form S-1 on Sep 15, 2025 for a proposed initial public offering on NYSE American under the ticker EMI, and has not yet priced. Its latest amendment was filed on Sep 28, 2026. Underwriters named in the filing: Financial and Inc.
Encore Medical, Inc. develops, manufactures and markets septal occlusion products, small implantable devices delivered by catheter to permanently repair certain cardiac defects, reducing the need for open heart surgery or lifetime drug therapy.
- Status
- Filed, not priced
- Ticker
- EMI
- Exchange
- NYSE American
- First filed
- Sep 15, 2025
- Latest amendment
- Sep 28, 2026
- Underwriters
- Financial and Inc
- Sector
- Healthcare
- Country / state
- MN
More on this listing for subscribers
- Amendment history
Every record in the database also has its full filing timeline, a daily-updated calendar, watchlist alerts and Excel export.
Then $99/month or $999/year. Cancel anytime.
Filings
- Registration statement (S-1) first filed Sep 15, 2025
- Latest amendment Sep 28, 2026
- All filings on EDGAR CIK 1838003
Other companies in the IPO pipeline
- Exxel Pharma, INC.Sep 19, 2025
- Guident Corp.Sep 18, 2025
- Global Development Engineering Co LtdSep 16, 2025
- Amatuhi Holdings, Inc.Sep 15, 2025
- Lendbuzz Inc.Sep 12, 2025
- SunHo BioTech Group LtdSep 11, 2025